0000899243-16-034294.txt : 20161123
0000899243-16-034294.hdr.sgml : 20161123
20161123160039
ACCESSION NUMBER: 0000899243-16-034294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161123
FILED AS OF DATE: 20161123
DATE AS OF CHANGE: 20161123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 SOUTH STREET
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 86 SOUTH STREET
CITY: HOPKINTON
STATE: MA
ZIP: 01748
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Driscoll Martin J
CENTRAL INDEX KEY: 0001339402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 162016575
MAIL ADDRESS:
STREET 1: C/O JAVELIN PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-23
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001339402
Driscoll Martin J
C/O SPRING BANK PHARMACEUTICALS, INC.
86 SOUTH STREET
HOPKINTON
MA
01748
1
1
0
0
President and CEO
Common Stock
2016-11-23
4
A
0
21900
9.12
A
46400
D
Warrant (right to buy)
10.79
2016-11-23
4
A
0
21900
0.00
A
2017-05-24
2021-11-23
Common Stock
21900
21900
D
/s/ Jonathan Freve
2016-11-23